Cost/benefit analysis of pharmacologic hemostasis

This publication has 12 references indexed in Scilit:

• The Hospital Cost (Fiscal Year 1991/1992) of a Simple Perioperative Allongeneic Red Blood Cell Transfusion During Elective Surgery at Duke University
  Anesthesia & Analgesia, 1994
• Prophylactic EACA Administration Minimizes Blood Replacement Therapy
  Anesthesiology, 1994
• On-site Prothrombin Time, Activated Partial Thromboplastin Time, and Platelet Count A Comparison between Whole Blood and Laboratory Assays with Coagulation Factor Analysis in Patients Presenting for Cardiac Surgery
  Anesthesiology, 1994
• Prevention of postbypass bleeding with tranexamic acid and ϵ-aminocaproic acid
  Journal of Cardiothoracic and Vascular Anesthesia, 1993
• Economic impact of inappropriate blood transfusions in coronary artery bypass graft surgery
  The American Journal of Medicine, 1993
• The Role of Desmopressin Acetate in Patients Undergoing Coronary Artery Bypass Surgery
  Anesthesiology, 1992
• Measuring costs and financial benefits in randomized controlled trials
  American Heart Journal, 1990
• DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor
  Blood, 1989
• Role of High Molecular Weight Kininogen in Contact Activation
  Seminars in Thrombosis and Hemostasis, 1987
• Surface activation of blood coagulation, fibrinolysis and kinin formation
  Nature, 1980